A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 16-Week Trial to Evaluate the Efficacy and Safety of FB-401 in Children, Adolescent and Adult Subjects (Ages 2 Years and Older) with Mild to Moderate Atopic Dermatitis.

Roseomonas mucosa (FB-401) - Forte Biosci

http://www.ncbi.nlm.nih.gov/pubmed/37579728

Amy S Paller; Eric Lawrence Simpson; Ian A Myles; Lawrence F Eichenfield; Michael E Jacobson

Aug 15, 2023